- Home
- VNDA vs PHT Comparison
VNDA vs PHT Comparison
Compare VNDA & PHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- PHT
- Stock Information
- Founded
- VNDA 2002
- PHT 2002
- Country
- VNDA United States
- PHT United States
- Employees
- VNDA N/A
- PHT N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- PHT Investment Managers
- Sector
- VNDA Health Care
- PHT Finance
- Exchange
- VNDA Nasdaq
- PHT Nasdaq
- Market Cap
- VNDA 270.2M
- PHT 230.3M
- IPO Year
- VNDA 2006
- PHT N/A
- Fundamental
- Price
- VNDA $5.09
- PHT $7.96
- Analyst Decision
- VNDA Strong Buy
- PHT
- Analyst Count
- VNDA 2
- PHT 0
- Target Price
- VNDA $15.50
- PHT N/A
- AVG Volume (30 Days)
- VNDA 775.4K
- PHT 85.5K
- Earning Date
- VNDA 11-06-2024
- PHT 01-01-0001
- Dividend Yield
- VNDA N/A
- PHT 8.76%
- EPS Growth
- VNDA N/A
- PHT N/A
- EPS
- VNDA N/A
- PHT 0.98
- Revenue
- VNDA $190,858,000.00
- PHT N/A
- Revenue This Year
- VNDA $6.70
- PHT N/A
- Revenue Next Year
- VNDA $51.03
- PHT N/A
- P/E Ratio
- VNDA N/A
- PHT $7.71
- Revenue Growth
- VNDA N/A
- PHT N/A
- 52 Week Low
- VNDA $3.30
- PHT $6.41
- 52 Week High
- VNDA $6.75
- PHT $7.60
- Technical
- Relative Strength Index (RSI)
- VNDA 59.66
- PHT 48.85
- Support Level
- VNDA $4.56
- PHT $7.73
- Resistance Level
- VNDA $4.89
- PHT $7.81
- Average True Range (ATR)
- VNDA 0.18
- PHT 0.05
- MACD
- VNDA 0.04
- PHT 0.00
- Stochastic Oscillator
- VNDA 66.67
- PHT 82.92
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.
About PHT Pioneer High Income Fund Inc.
Pioneer High Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income and to seek capital appreciation by investing predominantly in below investment grade (high-yield) debt securities, loans, and preferred stocks.